CSL Behring

PRIVIGEN

Manufacturer:

CSL Behring

Privigen HCPCS:

J1459

HCPCS Code Descriptor:

Injection, immune globulin (privigen), intravenous, non-lyophilized (e.g., liquid), 500 mg

Category:

J Code

Privigen NDCs:

44206-0439-40, 44206-0439-40, 44206-0438-20, 44206-0438-20, 44206-0437-10, 44206-0437-10, 44206-0436-05, 44206-0436-05

Primary Type:

Immunoglobulin

Generic/Specialty Status:

Single-Source

Route of Administration:

Intravenous

Potential NDC Listing Errors:

Our team did not identify any potential listing errors/discrepancies for the NDCs mapped to this HCPCS code.

About Privigen:

PRIVIGEN is an Immunoglobulin drug manufactured by CSL Behring and administered via the Intravenous route of administration. The J Code: J1459 is aligned to the drug PRIVIGEN.

ACCESS PRICING AND MORE BY REGISTERING

J1459 Added Date:

January 1, 2009

J1459 Effective Date:

January 1, 2009

J1459 Termination Date:

HCPCS Active

Privigen billing and coding information can be found through Csl Behring at the link below:
Privigen patient assistance information can be found through CSL Behring at the URL: https://www.cslbehring.com/patients/support-and-assistance
PRIVIGEN prescribing information can be found at the link below:
Our team has not yet identified a source of side effects information for PRIVIGEN. Please check back in a few weeks.